SE8101267L - Nya acylderivat av karnitin, forfarande for deras framstellning och terapeutisk anvendning av dem - Google Patents

Nya acylderivat av karnitin, forfarande for deras framstellning och terapeutisk anvendning av dem

Info

Publication number
SE8101267L
SE8101267L SE8101267A SE8101267A SE8101267L SE 8101267 L SE8101267 L SE 8101267L SE 8101267 A SE8101267 A SE 8101267A SE 8101267 A SE8101267 A SE 8101267A SE 8101267 L SE8101267 L SE 8101267L
Authority
SE
Sweden
Prior art keywords
derivatives
acyld
carnitin
procedure
preparation
Prior art date
Application number
SE8101267A
Other languages
English (en)
Other versions
SE452004B (sv
Inventor
C Cavazza
Witt P De
M O Tinti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of SE8101267L publication Critical patent/SE8101267L/sv
Publication of SE452004B publication Critical patent/SE452004B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8101267A 1980-03-06 1981-02-26 Acylderivat av karnitin och farmaceutisk komposition innehallande nemnda forening SE452004B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48099/80A IT1145362B (it) 1980-03-06 1980-03-06 Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico

Publications (2)

Publication Number Publication Date
SE8101267L true SE8101267L (sv) 1981-09-07
SE452004B SE452004B (sv) 1987-11-09

Family

ID=11264505

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101267A SE452004B (sv) 1980-03-06 1981-02-26 Acylderivat av karnitin och farmaceutisk komposition innehallande nemnda forening

Country Status (22)

Country Link
US (2) US4766222A (sv)
JP (1) JPS56139442A (sv)
AR (1) AR228591A1 (sv)
AT (1) AT376200B (sv)
AU (1) AU543799B2 (sv)
BE (1) BE887695A (sv)
CA (1) CA1178971A (sv)
CH (1) CH653008A5 (sv)
DE (1) DE3107743A1 (sv)
DK (1) DK154424C (sv)
ES (1) ES8201535A1 (sv)
FI (1) FI78680C (sv)
FR (1) FR2477536B1 (sv)
GB (1) GB2071091B (sv)
GR (1) GR74440B (sv)
IE (1) IE50959B1 (sv)
IL (1) IL62189A (sv)
IT (1) IT1145362B (sv)
LU (1) LU83183A1 (sv)
MX (1) MX155928A (sv)
NL (1) NL8101067A (sv)
SE (1) SE452004B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1238344B (it) * 1989-10-20 1993-07-13 Sigma Tau Ind Farmaceuti Estere della l-carnitina con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che lo contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
CA2389623A1 (en) 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
CA2561733A1 (en) * 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
JP6296433B2 (ja) * 2012-11-22 2018-03-20 国立大学法人山形大学 生体適合性ポリマー及びその製造方法並びにそれを製造するための新規化合物
JP2020522534A (ja) * 2017-06-06 2020-07-30 ウェイン ステート ユニバーシティＷａｙｎｅ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ カルニチン由来材料に関する方法および組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1108125A (fr) * 1953-05-08 1956-01-09 Laboratoires Labaz Soc D Procédé de préparation d'un dérivé stable de la carnitine
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
JPS5481963A (en) * 1977-12-13 1979-06-29 Ihachi Nosaka Roll paper holder for lavatory
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156769B (it) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di altri acil derivati della carnitina
IT1156840B (it) * 1978-06-27 1987-02-04 Sigma Tau Ind Farmaceuti Acil derivati della carnitina
JPS5554821A (en) * 1978-10-18 1980-04-22 Iseki Agricult Mach Discharging dust adjuster of thresher
US4518776A (en) * 1982-07-19 1985-05-21 Ciba Geigy Corporation Process for producing sulfonylureas
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US4707491A (en) * 1985-12-20 1987-11-17 Washington University Anticonvulsant γ-thiobutyrolactone derivatives

Also Published As

Publication number Publication date
BE887695A (fr) 1981-06-15
DK100181A (da) 1981-09-07
IL62189A (en) 1985-10-31
FI78680C (sv) 1989-09-11
JPS56139442A (en) 1981-10-30
AR228591A1 (es) 1983-03-30
MX155928A (es) 1988-05-24
DK154424B (da) 1988-11-14
ES500131A0 (es) 1982-01-01
AT376200B (de) 1984-10-25
IT1145362B (it) 1986-11-05
SE452004B (sv) 1987-11-09
AU6802881A (en) 1981-09-24
US4859698A (en) 1989-08-22
IT8048099A0 (it) 1980-03-06
LU83183A1 (fr) 1981-06-24
DE3107743A1 (de) 1981-12-03
DK154424C (da) 1989-05-22
NL8101067A (nl) 1981-10-01
ATA103981A (de) 1984-03-15
IE810359L (en) 1981-09-06
FR2477536B1 (fr) 1986-04-04
ES8201535A1 (es) 1982-01-01
FI78680B (fi) 1989-05-31
FI810695L (fi) 1981-09-07
IE50959B1 (en) 1986-08-20
FR2477536A1 (fr) 1981-09-11
US4766222A (en) 1988-08-23
GB2071091A (en) 1981-09-16
CA1178971A (en) 1984-12-04
IL62189A0 (en) 1981-03-31
GR74440B (sv) 1984-06-28
GB2071091B (en) 1984-09-12
CH653008A5 (it) 1985-12-13
AU543799B2 (en) 1985-05-02

Similar Documents

Publication Publication Date Title
FR2483912B1 (fr) Derives hydroxycarboxyles du compose ml-236b, leur procede de preparation et leur application therapeutique
SE8001685L (sv) Karcinostatiskt och immunostimulerande medel innehallande lysofosfolipid och fosfolipid och forfarande for framstellning derav
ATE106867T1 (de) 13-trans-retinsäureester.
FR2304597A1 (fr) Procede de preparation d'acides carboxyliques insatures
BE869721A (fr) Derives d'acides cycloalcoylindenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
IE810359L (en) Acyl derivatives of carnitine
IT1160443B (it) Procedimento per la preparazione di acidi 1,2-diidro-3h-pirrolo (1,2-a)-pirrol-1-carbossilici
ATE121293T1 (de) Verwendung eines stoffes, dessen hauptbestandteil ein triglyzerid ist, als wirkstoff mit biologischer wirkung auf die darmmucosa sowie zubereitung die diesen wirkstoff enthält.
LU79186A1 (fr) Procede de preparation d'acides 2-aryl-propioniques optiquement actifs
FR2309528A1 (fr) Procede de preparation de solutions organiques d'acides percarboxyliques
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
IT1119854B (it) Composizione farmaceutica comprendente l-carnitina per il trattamento di disfunzioni cardiache
ES515713A0 (es) "proceso para preparar insulina humana o los esteres b-30 de la misma".
IT7824796A0 (it) Procedimento per il trattamento del la colibacillosi neonatale e relativo composto farmaceutico
BE883698A (fr) Procede de preparation d'acides aliphatiques insatures et de leurs esters et catalyseurs utilises
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
FR2329651A1 (fr) Procede de preparation d'acides cyclopropane-carboxyliques
OA06792A (fr) Procédé de préparation de dérivés esters d'acides cyclopropane-carboxylique.
FR2299869A1 (fr) Procede de preparation d'acides (
FR2309530A1 (fr) Procede de preparation en continu d'acides percarboxyliques en solution organique
BE882360A (fr) Derives d'acides 3-heterocyclo-thiomethyl-7alpha-methoxy-7beta-acylamino-3-cephem-4-carboxyliques insatures
IL48785A0 (en) Pharmaceutical preparations for the treatment of coronary heart diseases
FR2309529A1 (fr) Procede de preparation en continu de solutions organiques d'acides percarboxyliques

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8101267-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8101267-6

Format of ref document f/p: F